Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | CD69 | Q07108 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14499030 | 0.88 | KMT2A (0.58) | KMT2AKDM4EPOLBGAAMAPT | |
| SCHEMBL3729436 | 0.87 | KMT2A (1.00) | KMT2AMCL1CD69KDM4EPKM | |
| SCHEMBL830740 | 0.87 | KMT2A (0.60) | KMT2ACD69KDM4EMAPTRAB9A | |
| SCHEMBL16005822 | 0.86 | KMT2A (0.56) | KMT2AKDM4EPOLBGAAMAPT | |
| SCHEMBL9501831 | 0.82 | POLB (0.56) | KMT2AMCL1KDM4EPOLBGAA | |
| SCHEMBL28044483 | 0.81 | KMT2A (0.53) | KMT2AMCL1CD69KDM4EPOLB | |
| SCHEMBL321504 | 0.81 | L3MBTL1 (0.56) | KMT2ACD69KDM4EPOLBPTGDR2 | |
| SCHEMBL28731750 | 0.79 | KMT2A (0.77) | KMT2AMCL1CD69KDM4EHTT | |
| SCHEMBL20509554 | 0.79 | ALDH1A1 (0.60) | KMT2ACD69KDM4EPOLBPTGDR2 | |
| SCHEMBL1195532 | 0.79 | TSHR (0.54) | KMT2APOLBHTTMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0539462-A1 | A METHOD FOR PREPARING 4-CHLORO-2-METHYLPHENOXYALKANOIC ACIDS | KVK AGRO A/S (DK) | 1993-05-05 | — | — | EP | claimed |
| WO-1992001663-A1 | A METHOD FOR PREPARING 4-CHLORO-2-METHYLPHENOXYALKANOIC ACIDS | KVK AGRO A/S (DK) | 1992-02-06 | — | — | WO | claimed |
| EP-2435407-B1 | ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | RAQUALIA PHARMA INC (JP) | 2019-12-25 | — | — | EP | disclosed |
| US-20150322052-A1 | ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | RAQUALIA PHARMA INC (JP) | 2015-11-12 | — | — | US | disclosed |
| US-20150322052-A1 | ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | RAQUALIA PHARMA INC (JP) | 2015-11-12 | — | — | US | disclosed |
| US-9101616-B2 | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers | RAQUALIA PHARMA INC. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-9101616-B2 | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers | RAQUALIA PHARMA INC. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-9012363-B2 | Granular controlled release agrochemical compositions and process for the preparation thereof | EVERRIS INTERNATIONAL B.V. (NL) | 2015-04-21 | — | — | US | disclosed |
| CN-104387157-A | Granular controlled release agrochemical compositions and process for the preparation thereof | OMS INVEST INC | 2015-03-04 | — | — | CN | disclosed |
| EP-2247571-B1 | DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE | UNIV JAGIELLONSKI (PL) | 2014-09-10 | — | — | EP | disclosed |
| CN-103112968-B | Method for treating high-COD (Chemical Oxygen Demand) components in phenoxyalkanoic acid production wastewater | SHANDONG WEIFANG RAINBOW CHEM | 2014-09-10 | — | — | CN | disclosed |
| US-20090062356-A1 | SUBSTITUTED BENZIMIDAZOLE DERIVATIVES | HOFFMANN-LA ROCHE, INC. | 2009-03-05 | — | — | US | disclosed |
| EP-1928231-A2 | GRANULAR CONTROLLED RELEASE AGROCHEMICAL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | OMS Investments, Inc. (US) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007041234-A2 | GRANULAR CONTROLLED RELEASE AGROCHEMICAL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | OMS INVESTMENTS, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| US-20070072775-A1 | Granular controlled release agrochemical compositions and process for the preparation thereof | OMS INVESTMENTS, INC. (US) | 2007-03-29 | — | — | US | disclosed |
| US-6696494-B2 | HUMAN IMMUNODEFICIENCY VIRUS | ENANTA PHARMACEUTICALS, INC. | 2004-02-24 | — | — | US | disclosed |
| US-20030207934-A1 | Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease | ENANTA PHARMACEUTICALS, INC. | 2003-11-06 | — | — | US | disclosed |
| WO-2003034989-A2 | α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE | ENANTA PHARMACEUTICALS, INC. (US) | 2003-05-01 | — | — | WO | disclosed |
| EP-0539462-A1 | A METHOD FOR PREPARING 4-CHLORO-2-METHYLPHENOXYALKANOIC ACIDS | KVK AGRO A/S (DK) | 1993-05-05 | — | — | EP | disclosed |
| WO-1992001663-A1 | A METHOD FOR PREPARING 4-CHLORO-2-METHYLPHENOXYALKANOIC ACIDS | KVK AGRO A/S (DK) | 1992-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062356-A1 | SUBSTITUTED BENZIMIDAZOLE DERIVATIVES | NR1H4, SLC10A1, FXR1 | KMT2A 4512/4885MCL1 3672/4885CD69 1745/4885 |
| US-20150322052-A1 | ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | CACNA1I, CACNA1G, CACNA1H | KMT2A 1762/4885MCL1 4154/4885CD69 3719/4885 |
| US-20030207934-A1 | Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease | DNPEP, ASPH, CTSC | KMT2A 1800/4885MCL1 810/4885CD69 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.